Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9612-9620

  Zhang, Wei ^a   Lonning, Scott M ^a   Mcguire, Travis C ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b USDA ARS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CAPSID PROTEIN; EPITOPE; GAG PROTEIN; MATRIX PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE DISEASE; KIDNEY CELL; LENTIVIRINAE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031798088     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9612-9620.1998     Document Type: Article

References (51)

1. Allen, G., M. Yeargan, L. R. Costa, and R. Cross. 1995. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 69:606-612.
2. Bailey, E. 1983. Population studies on the ELA system in American standardbred and thoroughbred mares. Anim. Blood Groups Biochem. Genet. 14:201-211.
3. Bernoco, D., G. Byrns, E. Bailey, and A. M. Lew. 1987. Evidence of a second polymorphic ELA class I (ELA-B) locus and gene order for three loci of the equine major histocompatibility complex. Anim. Genet. 18:103-118.
4. Biddison, W. E., M. S. Krangel, J. L. Strominger, F. E. Ward, G. M. Shearer, and S. Shaw. 1980. Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. Hum. Immunol. 1:225-232.
5. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Borrow, P., H. Lewicki, X. P. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
7. Braciale, T. J., M. T. Sweetser, L. A. Morrison, D. J. Kittlesen, and V. L. Braciale. 1989. Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin. Proc. Natl. Acad. Sci. USA 86:277-281.
8. Carpenter, S., L. H. Evans, M. Sevoian, and B. Chesebro. 1987. Role of the host immune response in selection of equine infectious anemia virus variants. J. Virol. 61:3783-3789.
9. Coggins, L. 1984. Carriers of equine infectious anemia virus. J. Am. Vet. Med. Assoc. 184:279-281.
10. Crawford, T. B., K. J. Wardrop, S. J. Tornquist, E. Reilich, K. M. Meyers, and T. C. McGuire. 1996. A primary production deficit in the thrombocytopenia of equine infectious anemia. J. Virol. 70:7842-7850.
11. Deng, Y. P., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507-1515.
12. Emini, E. A., W. A. Schleif, J. H. Nunberg, A. J. Conley, Y. Eda, S. Tokiyoshi, S. D. Putney, S. Matsushita, K. E. Cobb, C. M. Jett, et al. 1992. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355:728-730.
13. Evans, D. T., M. S. Piekarczyk, T. M. Allen, J. E. Boyson, M. Yeager, A. L. Hughes, F. M. Gotch, V. S. Hinshaw, and D. I. Watkins. 1997. Immunodominance of a single CTL epitope in a primate species with limited MHC class I polymorphism. J. Immunol. 159:1374-1382.
14. Goulder, P. J., A. K. Sewell, D. G. Lalloo, D. A. Price, J. A. Whelan, J. Evans, G. P. Taylor, G. Luzzi, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1997. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A0201 are influenced by epitope mutation. J. Exp. Med. 185:1423-1433.
15. Hammond, S. A., S. J. Cook, D. L. Lichtenstein, C. J. Issel, and R. C. Montelaro. 1997. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71:3840-3852.
16. Irwin, M. J., L. S. Laube, V. Lee, M. Austin, S. Chada, C. G. Anderson, K. Townsend, D. J. Jolly, and J. F. Warner. 1994. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J. Virol. 68:5036-5044.
17. Issel, C. J., D. W. Horohov, D. F. Lea, W. V. Adams, Jr., S. D. Hagius, J. M. McManus, A. C. Allison, and R. C. Montelaro. 1992. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66:3398-3408.
18. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512-1521.
19. Jolly, D. J., and J. F. Warner. 1990. Retroviral vectors as vaccines and immunotherapeutics. Semin. Immunol. 2:329-339.
20. Jolly, D. J., and J. F. Warner. 1991. Induction of anti-HIV-1 immune reponses by retroviral vectors. Biotechnol. Ther. 2:179-193.
21. Kawakami, T., L. Sherman, J. Dahlberg, A. Gazit, A. Yaniv, S. R. Tronick, and S. A. Aaronson. 1987. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology 158:300-312.
22. Klein, M. R., C. A. van-Baalen, A. M. Holwerda, S. R. Kerkhof-Garde, R. J. Bende, I. P. Keet, J. K. Eeftinck-Schattenkerk, A. D. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181: 1365-1372.
23. Kono, Y., K. Hirasawa, Y. Fukunaga, and T. Taniguchi. 1973. Resistance of horses infected chronically with equine infectious anemia virus against reinfection. Natl. Inst. Anim. Health Q. 13:173-181.
24. Kono, Y., K. Hirasawa, Y. Fukunaga, and T. Taniguchi. 1976. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl. Inst. Anim. Health Q. 16:8-15.
25. Kono, Y., K. Kobayashi, and Y. Fukunaga. 1973. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Gesamte Virusforsch. 41:1-10.
26. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
27. Langemeier, J. L., E. Bailey, and P. J. Henney. 1993. Linkage studies between the Tcp-1, Tcp-10, and Mhc-Eqca-A loci in the horse. Immunogenetics. 38:359-362.
28. Lieberman, J., J. A. Fabry, D. M. Fong, and G. R. Parkerson. 1997. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocyte response to HIV type 1 in an infected individual. AIDS Res. Hum. Retroviruses 13:383-392.
29. + cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 Gag. J. Virol. 65:4051-4056.
30. Lonning, S. M., W. Zhang, S. R. Leib, and T. C. McGuire. Equine infectious anemia virus-specific memory cytotoxic T lymphocytes efficiently lyse retroviral vector transduced target cells. Submitted for publication.
31. Marti, E., G. Szalai, D. F. Antczak, E. Bailey, H. Gerber, and S. Lazary. 1996. The equine major histocompatibility complex, p. 245-268. In L. B. Schook and S. J. Lamont (ed.), The major histocompatibility complex region of domestic animal species. CRC Press, Boca Raton, Fla.
32. McGuire, T. C., K. I. O'Rourke, T. V. Baszler, S. R. Leib, A. L. Brassfield, and W. C. Davis. 1994. Expression of functional protease and subviral particles by vaccinia virus containing equine infectious anaemia virus gag and 5′ pol genes. J. Gen. Virol. 75:895-900.
33. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J. Virol. 68:1459-1467.
34. McGuire, T. C., W. Zhang, M. T. Hines, P. J. Henney, and K. M. Byrne. 1997. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. Virology 238:85-93.
35. Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
36. Nakamura, Y., M. Kameoka, M. Tobiume, M. Kaya, K. Ohki, T. Yamada, and K. Ikuta. 1997. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein. Vaccine 15:489-496.
37. Nixon, D. F., and A. J. McMichael. 1991. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 5:1049-1059.
38. O'Rourke, K., L. E. Perryman, and T. C. McGuire. 1988. Antiviral, antiglycoprotein and neutralizing antibodies in foals with equine infectious anemia virus. J. Gen. Virol. 69:667-674.
39. Parham, P., and T. Ohta. 1996. Population biology of antigen presentation by MHC class I molecules. Science 272:67-74.
40. Perry, S. T., M. T. Flaherty, M. J. Kelley, D. L. Clabough, S. R. Tronick, L. Coggins, L. Whetter, C. R. Lengel, and F. Fuller. 1992. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J. Virol. 66:4085-4097.
41. Perryman, L. E., K. I. O'Rourke, and T. C. McGuire. 1988. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62:3073-3076.
42. Rinaldo, C., X. L. Huang, Z. F. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, and M. Cottrill. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
43. Riviere, Y., M. B. McChesney, F. Porrot, S. F. Tanneau, P. Sansonetti, O. Lopez, G. Pialoux, V. Feuillie, M. Mollereau, and S. Chamaret. 1995. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses 11:903-907.
44. Schuberth, H. J., I. Anders, U. Pape, and W. Leibold. 1992. One-dimensional isoelectric focusing and immunoblotting of equine major histocompatibility complex class I antigens. Anim. Genet. 23:87-95.
45. Shirai, M., S. Kozlowski, D. H. Margulies, and J. A. Berzofsky. 1997. Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop. J. Immunol. 158:3181-3188.
46. Song, E. S., V. Lee, C. D. Surh, A. Lynn, D. Brumm, D. J. Jolly, J. F. Warner, and S. Chada. 1997. Antigen presentation in retroviral vector-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 94:1943-1948.
47. Song, W., E. W. Collisson, J. Li, A. M. Wolf, J. H. Elder, C. K. Grant, and W. C. Brown. 1995. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein. Virology 209:390-399.
48. Stephens, R. M., J. W. Casey, and N. R. Rice. 1986. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus. Science 231: 589-594.
49. van-Baalen, C. A., M. R. Klein, R. C. Huisman, M. E. Dings, S. R. Kerkhof-Garde, A. M. Geretti, R. Gruters, C. A. van-Els, F. Miedema and A. D. Osterhaus. 1996. Fine-specificity of cytotoxic T lymphocytes which recognize cnserved epitopes of the Gag protein of human immunodeficiency virus type 1. J. Gen. Virol. 77:1659-1665.
50. Warner, J. F., C. G. Anderson, L. Laube, D. J. Jolly, K. Townsend, S. Chada, and D. St. Louis. 1991. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. AIDS Res. Hum. Retroviruses. 7:645-655.
51. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707-1711.